4//SEC Filing
SIDRANSKY DAVID 4
Accession 0001628280-22-026400
CIK 0000771856other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 2:27 PM ET
Size
8.7 KB
Accession
0001628280-22-026400
Insider Transaction Report
Form 4
SIDRANSKY DAVID
Director10% Owner
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2022-10-12−8,333→ 0 totalExercise: $3.21Exp: 2022-10-31→ Common Stock (8,333 underlying) - Exercise/Conversion
Common Stock
2022-10-12$3.21/sh+8,333$26,749→ 770,605 total - Tax Payment
Common Stock
2022-10-12$7.51/sh−3,562$26,751→ 767,043 total
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022.
- [F2]The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018
Documents
Issuer
CHAMPIONS ONCOLOGY, INC.
CIK 0000771856
Entity typeother
Related Parties
1- filerCIK 0001277161
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 2:27 PM ET
- Size
- 8.7 KB